CCRF Inc., Beijing, China
6 clinical trials · Sponsor
◉ Watch CCRF Inc., Beijing, China
| Record | Firm | Date |
|---|---|---|
| To Evaluate Whether IVUS-guided Drug-eluting Stent (DES) Implantation Leads to Better Clinical Outcomes Compared to Conventional Angiography in the Treatment of Chronic Complete Occlusion (CTO) Disease. (NCT04944615) | CCRF Inc., Beijing, China | 2022-10-21 |
| Multi Center Registry of Transcatheter Aortic Valve Replacement in Northeast China (NCT04988243) | CCRF Inc., Beijing, China | 2021-08-01 |
| A Prospective Evaluation of Clinical Impact of Physiology Versus Optical Coherence Tomography Guided PCI in STEMI Patients Without Undergoing Primary PCI (NCT04996277) | CCRF Inc., Beijing, China | 2021-07-31 |
| The Sensitivity and Specificity of CardioSimFFRct Analysis Software on Coronary Artery Stenosis (NCT04569669) | CCRF Inc., Beijing, China | 2020-10-09 |
| The Safety and Efficacy of DIOR Balloon in Coronary Bifurcation Lesions (NCT03820622) | CCRF Inc., Beijing, China | 2019-03-01 |
Track CCRF Inc., Beijing, China automatically
Every clearance here is in the API, with alerts when new ones post.